Klingman & Associates’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-1,370
Closed -$214K – 344
2025
Q2
$214K Buy
1,370
+14
+1% +$2.22K 0.01% 291
2025
Q1
$223K Sell
1,356
-7
-0.5% -$1.16K 0.01% 251
2024
Q4
$222K Sell
1,363
-341
-20% -$61K 0.01% 242
2024
Q3
$333K Buy
+1,704
New +$314K 0.02% 202
2016
Q4
– Sell
-875
Closed -$46K – 329
2016
Q3
$46K Buy
+875
New +$44.3K 0.01% 193

Other funds holding ZTS

Klingman & Associates's ZTS Position: Q3 2025 in Review

Klingman & Associates sold out of Zoetis (ZTS) in Q3 2025, closing a stake of 1,370 shares — an estimated $214K sold.

Klingman & Associates first reported a position in ZTS in Q3 2016 and held it in 5 quarters. The position peaked at $333K in Q3 2024. 1,806 funds tracked by Wall St. Rank hold ZTS as of Q3 2025.

  • Klingman & Associates reported no remaining Zoetis position as of Q3 2025 after selling out during the quarter.
  • Klingman & Associates sold 1,370 Zoetis shares in Q3 2025, an estimated $214K.
  • Klingman & Associates first reported a position in Zoetis in Q3 2016 and held it in 5 quarters.
  • Klingman & Associates's Zoetis position peaked at $333K in Q3 2024.
  • 1,806 funds tracked by Wall St. Rank held Zoetis as of Q3 2025.

Based on Klingman & Associates's 13F filing for Q3 2025, filed 27 Oct 2025.